annual CFF:
-$1.79B+$122.00M(+6.38%)Summary
- As of today (June 18, 2025), TEVA annual cash flow from financing activities is -$1.79 billion, with the most recent change of +$122.00 million (+6.38%) on December 31, 2024.
- During the last 3 years, TEVA annual CFF has risen by +$381.00 million (+17.54%).
- TEVA annual CFF is now -107.10% below its all-time high of $25.22 billion, reached on December 31, 2016.
Performance
TEVA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$1.74B-$1.07B(-158.75%)Summary
- As of today (June 18, 2025), TEVA quarterly cash flow from financing activities is -$1.74 billion, with the most recent change of -$1.07 billion (-158.75%) on March 31, 2025.
- Over the past year, TEVA quarterly CFF has dropped by -$1.59 billion (-1054.97%).
- TEVA quarterly CFF is now -106.87% below its all-time high of $25.37 billion, reached on September 30, 2016.
Performance
TEVA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$3.38B-$1.59B(-88.94%)Summary
- As of today (June 18, 2025), TEVA TTM cash flow from financing activities is -$3.38 billion, with the most recent change of -$1.59 billion (-88.94%) on March 31, 2025.
- Over the past year, TEVA TTM CFF has dropped by -$2.03 billion (-149.19%).
- TEVA TTM CFF is now -111.05% below its all-time high of $30.63 billion, reached on September 30, 2016.
Performance
TEVA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TEVA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.4% | -1055.0% | -149.2% |
| 3 y3 years | +17.5% | -10000.0% | -101.8% |
| 5 y5 years | +7.0% | -149.1% | -38.9% |
TEVA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.4% | +17.5% | <-9999.0% | at low | -165.0% | at low |
| 5 y | 5-year | -20.4% | +17.5% | <-9999.0% | at low | -165.0% | at low |
| alltime | all time | -107.1% | +68.8% | -106.9% | +30.4% | -111.0% | +44.3% |
TEVA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.74B(+158.8%) | -$3.38B(+88.9%) |
| Dec 2024 | -$1.79B(-6.4%) | -$674.00M(<-9900.0%) | -$1.79B(+5.8%) |
| Sep 2024 | - | $0.00(-100.0%) | -$1.69B(-25.4%) |
| Jun 2024 | - | -$966.00M(+539.7%) | -$2.27B(+67.1%) |
| Mar 2024 | - | -$151.00M(-73.8%) | -$1.36B(-29.0%) |
| Dec 2023 | -$1.91B(+28.6%) | -$576.00M(0.0%) | -$1.91B(-6.6%) |
| Sep 2023 | - | -$576.00M(+947.3%) | -$2.05B(+7.1%) |
| Jun 2023 | - | -$55.00M(-92.2%) | -$1.91B(-12.9%) |
| Mar 2023 | - | -$706.00M(-0.7%) | -$2.19B(+47.6%) |
| Dec 2022 | -$1.49B(-31.5%) | -$711.00M(+61.6%) | -$1.49B(+16.4%) |
| Sep 2022 | - | -$440.00M(+30.2%) | -$1.28B(-36.6%) |
| Jun 2022 | - | -$338.00M(<-9900.0%) | -$2.01B(+20.1%) |
| Mar 2022 | - | $2.00M(-100.4%) | -$1.68B(-22.8%) |
| Dec 2021 | -$2.17B(+15.2%) | -$501.00M(-57.4%) | -$2.17B(+20.9%) |
| Sep 2021 | - | -$1.18B(>+9900.0%) | -$1.80B(+7.2%) |
| Jun 2021 | - | -$1.00M(-99.8%) | -$1.68B(-0.1%) |
| Mar 2021 | - | -$493.00M(+294.4%) | -$1.68B(-11.0%) |
| Dec 2020 | -$1.89B(-2.1%) | -$125.00M(-88.2%) | -$1.89B(-5.8%) |
| Sep 2020 | - | -$1.06B(>+9900.0%) | -$2.00B(-16.8%) |
| Jun 2020 | - | -$3.00M(-99.6%) | -$2.40B(-1.3%) |
| Mar 2020 | - | -$700.00M(+190.5%) | -$2.44B(+26.5%) |
| Dec 2019 | -$1.93B(-42.5%) | -$241.00M(-83.5%) | -$1.93B(-11.8%) |
| Sep 2019 | - | -$1.46B(+4074.3%) | -$2.18B(+52.9%) |
| Jun 2019 | - | -$35.00M(-81.5%) | -$1.43B(-1.4%) |
| Mar 2019 | - | -$189.00M(-62.1%) | -$1.45B(-56.8%) |
| Dec 2018 | -$3.35B(-41.7%) | -$499.00M(-29.2%) | -$3.35B(-37.5%) |
| Sep 2018 | - | -$705.00M(+1158.9%) | -$5.36B(-2.2%) |
| Jun 2018 | - | -$56.00M(-97.3%) | -$5.48B(-9.8%) |
| Mar 2018 | - | -$2.09B(-16.6%) | -$6.07B(+5.6%) |
| Dec 2017 | -$5.75B(-122.8%) | -$2.51B(+203.8%) | -$5.75B(+45.8%) |
| Sep 2017 | - | -$825.00M(+26.7%) | -$3.94B(-117.7%) |
| Jun 2017 | - | -$651.00M(-63.2%) | $22.25B(-4.0%) |
| Mar 2017 | - | -$1.77B(+152.2%) | $23.18B(-8.1%) |
| Dec 2016 | $25.22B(+424.8%) | -$701.00M(-102.8%) | $25.22B(-17.7%) |
| Sep 2016 | - | $25.37B(+8993.9%) | $30.63B(+634.4%) |
| Jun 2016 | - | $279.00M(+4.5%) | $4.17B(-16.2%) |
| Mar 2016 | - | $267.00M(-94.3%) | $4.98B(+3.6%) |
| Dec 2015 | $4.80B(-302.3%) | $4.71B(-532.6%) | $4.80B(-1055.3%) |
| Sep 2015 | - | -$1.09B(-200.3%) | -$503.00M(-295.0%) |
| Jun 2015 | - | $1.09B(+1068.8%) | $258.00M(-115.7%) |
| Mar 2015 | - | $93.00M(-115.7%) | -$1.65B(-30.6%) |
| Dec 2014 | -$2.38B(-38.8%) | -$593.00M(+80.2%) | -$2.38B(-1.1%) |
| Sep 2014 | - | -$329.00M(-59.8%) | -$2.40B(+3.1%) |
| Jun 2014 | - | -$819.00M(+29.2%) | -$2.33B(+3.1%) |
| Mar 2014 | - | -$634.00M(+2.4%) | -$2.26B(-41.9%) |
| Dec 2013 | -$3.88B(+131.4%) | -$619.00M(+141.8%) | -$3.88B(+29.5%) |
| Sep 2013 | - | -$256.00M(-65.8%) | -$3.00B(-9.5%) |
| Jun 2013 | - | -$748.00M(-66.9%) | -$3.31B(-0.4%) |
| Mar 2013 | - | -$2.26B(-949.6%) | -$3.33B(+98.2%) |
| Dec 2012 | -$1.68B(-150.3%) | $266.00M(-146.7%) | -$1.68B(-178.1%) |
| Sep 2012 | - | -$570.00M(-25.1%) | $2.15B(-37.1%) |
| Jun 2012 | - | -$761.00M(+24.1%) | $3.42B(-2.2%) |
| Mar 2012 | - | -$613.00M(-115.0%) | $3.49B(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $3.34B(+482.2%) | $4.09B(+486.2%) | $3.34B(-351.0%) |
| Sep 2011 | - | $698.00M(-202.0%) | -$1.33B(-40.4%) |
| Jun 2011 | - | -$684.00M(-11.2%) | -$2.23B(>+9900.0%) |
| Mar 2011 | - | -$770.00M(+34.4%) | -$22.00M(-103.8%) |
| Dec 2010 | $573.00M(-125.3%) | -$573.00M(+180.9%) | $573.00M(-38.6%) |
| Sep 2010 | - | -$204.00M(-113.4%) | $933.00M(+288.8%) |
| Jun 2010 | - | $1.52B(-971.4%) | $240.00M(-109.9%) |
| Mar 2010 | - | -$175.00M(-17.8%) | -$2.42B(+6.7%) |
| Dec 2009 | -$2.27B(-266.8%) | -$213.00M(-76.3%) | -$2.27B(+2444.9%) |
| Sep 2009 | - | -$897.00M(-20.7%) | -$89.00M(-112.3%) |
| Jun 2009 | - | -$1.13B(+4612.5%) | $724.00M(-40.8%) |
| Mar 2009 | - | -$24.00M(-101.2%) | $1.22B(-10.0%) |
| Dec 2008 | $1.36B(-475.1%) | $1.96B(-2436.9%) | $1.36B(-278.4%) |
| Sep 2008 | - | -$84.00M(-86.7%) | -$761.00M(-17.3%) |
| Jun 2008 | - | -$633.00M(-665.2%) | -$920.00M(+221.7%) |
| Mar 2008 | - | $112.00M(-171.8%) | -$286.00M(-21.0%) |
| Dec 2007 | -$362.00M(-117.9%) | -$156.00M(-35.8%) | -$362.00M(-31.9%) |
| Sep 2007 | - | -$243.00M(<-9900.0%) | -$531.30M(-1.9%) |
| Jun 2007 | - | $1.00M(-97.2%) | -$541.80M(+3.2%) |
| Mar 2007 | - | $36.00M(-111.1%) | -$525.00M(-125.9%) |
| Dec 2006 | $2.02B(-746.6%) | -$325.30M(+28.3%) | $2.02B(-25.0%) |
| Sep 2006 | - | -$253.50M(-1524.2%) | $2.70B(-3.5%) |
| Jun 2006 | - | $17.80M(-99.3%) | $2.80B(+8.3%) |
| Mar 2006 | - | $2.58B(+636.9%) | $2.58B(-924.8%) |
| Dec 2005 | -$313.00M(-136.7%) | $350.80M(-323.9%) | -$313.00M(-59.1%) |
| Sep 2005 | - | -$156.70M(-20.6%) | -$764.40M(+6.9%) |
| Jun 2005 | - | -$197.40M(-36.3%) | -$714.80M(+31.2%) |
| Mar 2005 | - | -$309.70M(+207.9%) | -$544.80M(-163.9%) |
| Dec 2004 | $852.00M(+2778.4%) | -$100.60M(-6.1%) | $852.00M(-13.6%) |
| Sep 2004 | - | -$107.10M(+290.9%) | $986.60M(-8.7%) |
| Jun 2004 | - | -$27.40M(-102.5%) | $1.08B(-2.5%) |
| Mar 2004 | - | $1.09B(+3097.4%) | $1.11B(+3643.6%) |
| Dec 2003 | $29.60M(-91.2%) | $34.00M(-361.5%) | $29.60M(-93.1%) |
| Sep 2003 | - | -$13.00M(<-9900.0%) | $428.20M(+0.8%) |
| Jun 2003 | - | $0.00(-100.0%) | $424.70M(+7.4%) |
| Mar 2003 | - | $8.60M(-98.0%) | $395.50M(+17.2%) |
| Dec 2002 | $337.50M(+26.5%) | $432.60M(-2721.8%) | $337.50M(-409.7%) |
| Sep 2002 | - | -$16.50M(-43.5%) | -$108.98M(-131.5%) |
| Jun 2002 | - | -$29.20M(-40.9%) | $345.47M(+1.9%) |
| Mar 2002 | - | -$49.40M(+255.8%) | $339.11M(+27.1%) |
| Dec 2001 | $266.72M(+0.4%) | -$13.88M(-103.2%) | $266.72M(-4.9%) |
| Sep 2001 | - | $437.95M(-1331.5%) | $280.60M(-278.3%) |
| Jun 2001 | - | -$35.56M(-70.8%) | -$157.35M(+29.2%) |
| Mar 2001 | - | -$121.79M | -$121.79M |
| Dec 2000 | $265.71M(+75.4%) | - | - |
| Dec 1999 | $151.48M(+174.6%) | - | - |
| Dec 1998 | $55.16M(-141.0%) | - | - |
| Dec 1997 | -$134.50M(-202.5%) | - | - |
| Dec 1996 | $131.20M(+226.4%) | - | - |
| Dec 1995 | $40.20M(+0.8%) | - | - |
| Dec 1994 | $39.90M(-10.5%) | - | - |
| Dec 1993 | $44.60M(+85.8%) | - | - |
| Dec 1992 | $24.00M(-31.8%) | - | - |
| Dec 1991 | $35.20M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CFF year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CFF year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM cash flow from financing activities?
- What is the all time high TTM CFF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CFF year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cash flow from financing activities?
The current annual CFF of TEVA is -$1.79B
What is the all time high annual CFF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cash flow from financing activities is $25.22B
What is Teva Pharmaceutical Industries Limited annual CFF year-on-year change?
Over the past year, TEVA annual cash flow from financing activities has changed by +$122.00M (+6.38%)
What is Teva Pharmaceutical Industries Limited quarterly cash flow from financing activities?
The current quarterly CFF of TEVA is -$1.74B
What is the all time high quarterly CFF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from financing activities is $25.37B
What is Teva Pharmaceutical Industries Limited quarterly CFF year-on-year change?
Over the past year, TEVA quarterly cash flow from financing activities has changed by -$1.59B (-1054.97%)
What is Teva Pharmaceutical Industries Limited TTM cash flow from financing activities?
The current TTM CFF of TEVA is -$3.38B
What is the all time high TTM CFF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM cash flow from financing activities is $30.63B
What is Teva Pharmaceutical Industries Limited TTM CFF year-on-year change?
Over the past year, TEVA TTM cash flow from financing activities has changed by -$2.03B (-149.19%)